STI Screening — What Tests to Get, When, and What Results Mean

Screening recommendations depend on your age, sexual activity, and risk factors. Here's what the CDC and ACOG recommend as a baseline — your provider can adjust based on your individual situation.

Chlamydia and gonorrhea: annual screening for all sexually active women under 25. For women 25 and older, screening is recommended if you have a new partner, multiple partners, or a partner with an STI. These are the most common bacterial STIs and are frequently asymptomatic — up to 70% of chlamydia infections cause no symptoms.

HIV: at least one screening test for everyone aged 13–64, with annual screening for those at higher risk (new or multiple partners, IV drug use, partner with HIV). Early detection dramatically improves outcomes and prevents transmission.

Syphilis: screening recommended for pregnant women (at first prenatal visit), men who have sex with men, people with HIV, and those with multiple partners. Syphilis rates have risen sharply in recent years, making this increasingly important.

Hepatitis B and C: Hep B screening for pregnant women and those at risk; Hep C screening at least once for all adults, plus anyone who has ever injected drugs.

Herpes (HSV): routine screening is not recommended for asymptomatic individuals because blood tests have high false-positive rates and results can cause significant anxiety without clear clinical benefit. Testing is appropriate if you have symptoms or a known exposure.

Trichomoniasis: screening recommended annually for women with HIV; consider testing if you have symptoms (frothy discharge, odor, itching) or BV that doesn't resolve.

A practical approach: if you're sexually active, request a comprehensive panel annually or with each new partner. Say "I'd like a full STI screening" — don't assume your annual exam automatically includes it, because it often doesn't.

STI testing is far less intimidating than most people imagine. Understanding what to expect can remove a major barrier to getting screened.

Urine test: chlamydia and gonorrhea are most commonly tested via a simple urine sample — you just pee in a cup. No swab, no speculum, no pain. This is a nucleic acid amplification test (NAAT), which is the gold standard for these infections.

Vaginal swab: your provider may collect a vaginal swab during a pelvic exam, or — increasingly — you can do a self-collected vaginal swab yourself. Self-swabs are just as accurate as provider-collected samples for chlamydia and gonorrhea and are becoming more widely available. Trichomoniasis can also be detected via vaginal swab.

Blood draw: HIV, syphilis, hepatitis B, hepatitis C, and herpes (when indicated) are all tested through a standard blood sample from your arm. Rapid HIV tests using a finger prick can provide results in 20 minutes, though a positive rapid test requires confirmatory blood work.

Physical examination: your provider may visually examine the vulva, vagina, and cervix for signs of infection — sores, warts, unusual discharge, or inflammation. This is part of the clinical evaluation, not a separate test.

Pharyngeal and rectal swabs: if you've had oral or anal sex, throat and rectal swabs can test for chlamydia and gonorrhea at these sites. Standard urine and vaginal tests don't detect infections in these locations — so mentioning your sexual practices helps your provider order the right tests.

The entire process usually takes less than 15 minutes. Results are typically available within 2–7 days depending on the lab.

Every STI test has a window period — the time between potential exposure and when the test can reliably detect the infection. Testing too early can produce a false negative, which is why understanding these timelines matters.

Chlamydia and gonorrhea: NAAT tests become reliable about 2 weeks after exposure. Testing earlier may miss a recent infection. If you had a known exposure, test at 2 weeks and consider repeating at 4 weeks if the initial test is negative.

HIV: fourth-generation combination tests (antigen/antibody tests, which are now standard) can detect infection as early as 18–45 days after exposure. Most infections are detectable by 4 weeks, but a conclusive negative result requires testing at 45 days. Older antibody-only tests have a longer window of up to 90 days. If you've had a high-risk exposure within 72 hours, ask about post-exposure prophylaxis (PEP), which can prevent infection.

Syphilis: blood tests typically become positive 3–6 weeks after exposure, though it can take up to 90 days. If you have a suspicious sore (chancre), your provider may be able to test it directly with a different method.

Hepatitis B: detectable by 4–10 weeks after exposure via surface antigen testing.

Hepatitis C: antibody tests become reliable at about 8–11 weeks. RNA tests (which detect the virus directly) can detect infection as early as 1–2 weeks.

Herpes (HSV): blood tests for antibodies take 2–12 weeks to become reliable after exposure. Swab testing of an active sore provides immediate results.

Practical advice: if you're testing after a specific exposure, share the timeline with your provider so they can interpret results accurately and schedule follow-up testing if needed. A single negative test immediately after exposure doesn't rule out infection.

A positive STI result can feel overwhelming, but it's important to remember: most STIs are either curable or very manageable, and getting diagnosed means you can protect both your health and your partners.

Bacterial STIs (chlamydia, gonorrhea, syphilis) are curable with antibiotics. Chlamydia is treated with a simple course of doxycycline (7 days). Gonorrhea is treated with a single injection of ceftriaxone. Syphilis is treated with penicillin injection(s). After treatment, you should abstain from sex for 7 days and get retested at 3 months to ensure the infection has cleared and you haven't been reinfected.

Trichomoniasis is cured with a single dose of metronidazole or tinidazole.

Herpes (HSV) is not curable but is highly manageable. Antiviral medications (valacyclovir, acyclovir) reduce outbreak frequency, severity, and transmission risk. Many people with herpes have infrequent or no outbreaks after the first year. It's one of the most common infections — roughly 1 in 6 adults has genital HSV-2 — and it does not define your worth or your future relationships.

HIV is not curable but is now a manageable chronic condition. Antiretroviral therapy (ART) can reduce viral load to undetectable levels, which means the virus cannot be transmitted sexually (U=U: Undetectable = Untransmittable). People on effective treatment have near-normal life expectancy.

Partner notification: informing current and recent sexual partners is important so they can be tested and treated, breaking the chain of transmission. Many health departments offer anonymous partner notification services if direct conversations feel too difficult.

Emotional support: a diagnosis can trigger shame, anxiety, or grief — all valid responses to a challenging moment. STIs are not moral failings. They're infections, like strep throat or the flu, that happen to be transmitted sexually. If you're struggling, reach out to a counselor or support community.

Yes — and this is precisely why routine screening is so important. Many of the most consequential STIs produce no symptoms for weeks, months, or even years, silently causing damage or being transmitted to partners.

Chlamydia is asymptomatic in up to 70–80% of women. Without screening, it can silently ascend to the uterus and fallopian tubes, causing pelvic inflammatory disease (PID), which can lead to chronic pelvic pain, ectopic pregnancy, and tubal factor infertility. Chlamydia is the leading preventable cause of infertility worldwide — and it's entirely curable with a short course of antibiotics if caught early.

Gonorrhea is asymptomatic in up to 50% of women. Like chlamydia, untreated gonorrhea can cause PID and fertility complications. It can also be carried asymptomatically in the throat and rectum.

HIV can be asymptomatic for years after the initial acute infection (which may cause flu-like symptoms that are easy to dismiss). Without testing, people can unknowingly transmit the virus during this clinically silent period.

HPV infections are usually asymptomatic. Most HPV infections clear on their own within 1–2 years, but persistent infection with high-risk strains (especially HPV 16 and 18) can cause cervical cell changes that progress to cervical cancer over years to decades — which is why Pap smears and HPV testing exist.

Syphilis has a primary stage (a painless sore that heals on its own) and a secondary stage (rash, flu-like symptoms that also resolve). It then enters a latent phase with no symptoms at all — but untreated, it can progress to devastating tertiary syphilis affecting the brain, heart, and other organs years later.

Herpes: many people with HSV-2 never have recognized outbreaks but can still shed the virus and transmit it.

The takeaway: "I feel fine" is not a reliable STI status. Regular screening is the only way to know.

Talking about STI testing with a partner can feel vulnerable, but it's a sign of maturity and mutual respect — and most people respond better than you'd expect when the conversation is framed well.

Timing matters. Bring it up before you're in a sexual situation — not in the heat of the moment. A calm, private setting works best: over dinner, during a walk, or in a relaxed conversation at home. Avoid framing it as an accusation or interrogation.

Lead with yourself. Starting with your own testing normalizes the conversation. Try: "I got tested recently and everything came back clear. Have you been tested?" or "I make it a habit to get tested between partners — it's just something I do for my health. Would you be up for doing it too?"

Frame it as a shared responsibility. "I think it would be great for both of us to get tested before we stop using condoms" positions testing as a team decision rather than a demand.

Acknowledge the awkwardness. "I know this can feel weird to talk about, but it's important to me" shows self-awareness and makes the conversation more human.

If they resist: a partner who refuses to get tested or reacts with anger or dismissiveness is telling you something important about how they handle health decisions and difficult conversations. You have every right to make testing a prerequisite for certain sexual activities.

Practical options to make it easier: some clinics offer couples testing appointments. At-home STI test kits are widely available and allow testing in the privacy of your own home. Many telehealth platforms can order lab work you can complete at a nearby lab without an in-person appointment.

Remember: asking about STI testing isn't a sign of distrust — it's a sign that you take your health and your partner's health seriously.

HPV (human papillomavirus) is the most common sexually transmitted infection — so common that nearly all sexually active people will contract at least one strain at some point. Most infections are harmless and clear on their own, but persistent infection with high-risk strains can cause cervical cancer, making screening and vaccination critically important.

The HPV vaccine (Gardasil 9) protects against 9 HPV strains, including the high-risk types responsible for approximately 90% of cervical cancers (HPV 16 and 18) and the strains causing 90% of genital warts (HPV 6 and 11). It's recommended for everyone aged 9–26 and is approved for adults up to age 45. The vaccine is most effective when given before HPV exposure, but it provides benefit even for those who've already been sexually active, since most people haven't been exposed to all 9 strains.

Pap smears (cervical cytology) screen for abnormal cervical cells that could indicate precancerous changes. Current screening guidelines from the USPSTF and ACOG recommend:

- Ages 21–29: Pap smear every 3 years (HPV testing alone is not recommended in this age group because transient HPV infections are extremely common). - Ages 30–65: Pap smear every 3 years, HPV testing alone every 5 years, or co-testing (Pap + HPV) every 5 years. Any of these strategies is acceptable. - Over 65: screening can stop if you've had adequate prior screening with normal results.

Abnormal results don't mean cancer. Most abnormal Paps show low-grade changes (LSIL or ASC-US) that reflect transient HPV infection and resolve without treatment. Your provider will determine whether to monitor with repeat testing or investigate further with colposcopy (a closer examination of the cervix).

High-grade changes (HSIL) require intervention — typically a colposcopy with biopsy and, if confirmed, a minor procedure to remove the abnormal tissue before it can progress. When caught at this stage, cervical cancer is almost entirely preventable.

Cervical cancer screening is one of the most successful cancer prevention programs in medical history. Regular Pap smears have reduced cervical cancer deaths by over 70% since their introduction.